Literature DB >> 30687632

The sick lobe hypothesis, field cancerisation and the new era of precision breast surgery.

Mona P Tan1, Tibor Tot2.   

Abstract

Understanding the ductal anatomy of the breast provides insights into tumorigenesis, which in turn offers guidance on therapeutic decisions. In this regard, the sick lobe hypothesis, which states that cancer arises from genetically unstable cells through mutations acquired in utero, forms the basis of malignant transformation. These 'at risk' cells line the mammary ductal-lobular system of a single 'sick' lobe and when exposed to noxious events in the surrounding microenvironment, further genetic changes occur which completes conversion to malignancy, in certain defined patterns. This review explores how anatomy, pathology and genomics can merge, not only to guide optimum surgery, but also to provide a more comprehensive portal for precision medicine.

Entities:  

Keywords:  Breast cancer; breast conservation treatment (BCT); field cancerisation; multifocal/multicentric breast cancer; precision breast surgery; sick lobe theory

Year:  2018        PMID: 30687632      PMCID: PMC6323249          DOI: 10.21037/gs.2018.09.08

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  44 in total

Review 1.  An atlas of mouse mammary gland development.

Authors:  M M Richert; K L Schwertfeger; J W Ryder; S M Anderson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-04       Impact factor: 2.673

2.  Alternative approaches for oncoplastic breast surgery.

Authors:  Mona Tan; Owen Ung
Journal:  Ann Surg Oncol       Date:  2010-06-05       Impact factor: 5.344

Review 3.  Breast cancer precursors revisited: molecular features and progression pathways.

Authors:  Maria A Lopez-Garcia; Felipe C Geyer; Magali Lacroix-Triki; Caterina Marchió; Jorge S Reis-Filho
Journal:  Histopathology       Date:  2010-05-24       Impact factor: 5.087

Review 4.  DCIS, cytokeratins, and the theory of the sick lobe.

Authors:  Tibor Tot
Journal:  Virchows Arch       Date:  2005-05-31       Impact factor: 4.064

5.  "Residual" mammary carcinoma following simulated partial mastectomy.

Authors:  P P Rosen; A A Fracchia; J A Urban; D Schottenfeld; G F Robbins
Journal:  Cancer       Date:  1975-03       Impact factor: 6.860

6.  I. The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894.

Authors:  W S Halsted
Journal:  Ann Surg       Date:  1894-11       Impact factor: 12.969

Review 7.  Allelic imbalances of the egfr gene as key events in breast cancer progression--the concept of committed progenitor cells.

Authors:  K Agelopoulos; H Buerger; B Brandt
Journal:  Curr Cancer Drug Targets       Date:  2008-08       Impact factor: 3.428

8.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

Authors:  Bernard Fisher; Stewart Anderson; John Bryant; Richard G Margolese; Melvin Deutsch; Edwin R Fisher; Jong-Hyeon Jeong; Norman Wolmark
Journal:  N Engl J Med       Date:  2002-10-17       Impact factor: 91.245

9.  Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer.

Authors:  Umberto Veronesi; Natale Cascinelli; Luigi Mariani; Marco Greco; Roberto Saccozzi; Alberto Luini; Marisel Aguilar; Ettore Marubini
Journal:  N Engl J Med       Date:  2002-10-17       Impact factor: 91.245

10.  Human breast duct anatomy, the 'sick lobe' hypothesis and intraductal approaches to breast cancer.

Authors:  James J Going; Timothy J Mohun
Journal:  Breast Cancer Res Treat       Date:  2006-04-27       Impact factor: 4.872

View more
  3 in total

1.  Implications of the evidence for breast conservation therapy in BRCA-gene mutation carriers.

Authors:  Mona P Tan
Journal:  Br J Radiol       Date:  2020-02-26       Impact factor: 3.039

Review 2.  Learning to distinguish progressive and non-progressive ductal carcinoma in situ.

Authors:  Anna K Casasent; Mathilde M Almekinders; Charlotta Mulder; Proteeti Bhattacharjee; Deborah Collyar; Alastair M Thompson; Jos Jonkers; Esther H Lips; Jacco van Rheenen; E Shelley Hwang; Serena Nik-Zainal; Nicholas E Navin; Jelle Wesseling
Journal:  Nat Rev Cancer       Date:  2022-10-19       Impact factor: 69.800

Review 3.  X-ray Dark-Field Imaging (XDFI)-a Promising Tool for 3D Virtual Histopathology.

Authors:  Daisuke Shimao; Naoki Sunaguchi; Tetsuya Yuasa; Masami Ando; Kensaku Mori; Rajiv Gupta; Shu Ichihara
Journal:  Mol Imaging Biol       Date:  2021-02-23       Impact factor: 3.488

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.